North America Clinical Trial Supply & Logistics Market to Grow with a CAGR of 6.81% through 2029

Rise in biopharmaceutical research advancements is expected to drive the North America Clinical Trial Supply & Logistics Market growth in the forecast period, 2025-2029.

According to TechSci Research report, “North America Clinical Trial Supply & Logistics Market – By Country, Competition, Forecast & Opportunities, 2029”, the North America Clinical Trial Supply & Logistics Market stood at USD 1.2 billion in 2023 and is anticipated to grow with a CAGR of 6.81% in the forecast period through 2029. One of the primary drivers fueling the growth of the North America Clinical Trial Supply & Logistics market is the escalating number of clinical trials conducted in the region. With the United States and Canada at the forefront of pharmaceutical research and development, a multitude of companies are engaging in clinical trials to bring new drugs and therapies to market. This surge in clinical trial activity directly translates into a heightened demand for reliable and streamlined supply chain services, encompassing packaging, labeling, storage, and distribution of investigational products. The continuous evolution of biopharmaceutical research is another pivotal factor propelling the demand for specialized clinical trial supply and logistics services. As the industry witnesses groundbreaking developments in areas like genomics, precision medicine, and biologics, the nature of clinical trials becomes more complex. The need for customized supply chain solutions, including temperature-controlled logistics for biologics and personalized medicines, is on the rise. This trend is reshaping the landscape of clinical trial logistics, with a focus on ensuring the integrity and stability of sensitive investigational products.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "North America Clinical Trial Supply & Logistics Market”

The North America Clinical Trial Supply & Logistics Market is segmented into Service, Therapeutic Area, Phase, Country Distribution and Company.

Based on the Phase, Phase III emerged as the dominant segment in the North America market for North America Clinical Trial Supply & Logistics Market in 2023. Phase III trials are characterized by their large scale, involving a substantial number of participants across multiple sites and often conducted on an international scale. The complexity of these trials, which may include diverse patient populations, various geographic locations, and rigorous study designs, necessitates sophisticated supply chain and logistics solutions. The sheer scale and intricacy of Phase III trials amplify the demand for efficient and reliable clinical trial supply services. Many Phase III trials involve global collaboration, with research sites spanning multiple countries. The coordination and management of clinical trial supplies across diverse regions, each with its regulatory requirements and logistical challenges, further amplify the demand for specialized supply chain solutions. The ability to seamlessly navigate global logistics complexities becomes essential during Phase III trials, contributing to the high demand for supply and logistics services.

Based on region, Canada emerged as the fastest growing country in the North America Clinical Trial Supply & Logistics Market in 2023. Canada has a robust healthcare system and well-established research infrastructure, including world-class hospitals, research institutions, and universities. This infrastructure can facilitate efficient clinical trial operations, from recruitment of participants to the delivery of trial supplies, leading to growth in the clinical trial supply and logistics market.  Increased investment in healthcare and pharmaceutical research, coupled with a culture of innovation, could have contributed to the growth of the clinical trial sector in Canada. Pharmaceutical companies and research organizations may be attracted to Canada's innovative ecosystem, leading to an expansion of clinical trial activities and, consequently, the supply and logistics market. Canada's multicultural society provides access to a diverse patient population, which is essential for conducting comprehensive clinical trials that represent different demographic groups. Pharmaceutical companies conducting trials in Canada may benefit from this diversity, driving demand for clinical trial supply and logistics services.

Major companies operating in North America Clinical Trial Supply & Logistics Market are:

• Thermo Fisher Scientific Inc.
• Catalent, Inc.
• Parexel International (MA) Corporation
• Almac Group Inc
• Marken LLC
• Piramal Pharma Solutions
• Evoke Health LLC
• DHL International Ltd
• FedEx Corporation
• Packaging Coordinators Inc.

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The North America Clinical Trial Supply & Logistics Market is poised for substantial growth in the coming years. With an increasing emphasis on personalized medicine, innovative therapies, and the globalization of clinical trials, the demand for specialized supply chain solutions is expected to surge. The region's robust pharmaceutical and biotechnology industry, particularly in the United States, contributes significantly to the market's growth. The evolution toward decentralized trials, advancements in biopharmaceuticals, and the integration of cutting-edge technologies in logistics are anticipated to fuel expansion. As clinical trials become more complex and diverse, the North America Clinical Trial Supply & Logistics market is positioned to play a pivotal role in supporting the seamless movement of investigational products, ultimately contributing to advancements in healthcare and the development of novel therapeutic solutions.” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“North America Clinical Trial Supply & Logistics Market By Service (Logistics & distribution, Storage & retention, Packaging, labeling, and blinding, Manufacturing, Comparator sourcing, other services), By Therapeutic Area (Oncology, Cardiovascular Diseases, Respiratory Diseases, CNS And Mental Disorders, Others), By Phase (Phase I, Phase II, Phase III, Phase IV), By Country, Competition, Forecast and Opportunities, 2019-2029F”, has evaluated the future growth potential of North America Clinical Trial Supply & Logistics Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in North America Clinical Trial Supply & Logistics Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: [email protected]               

Website: www.techsciresearch.com